Indications for Systemic and Genetic Testing in Patients with Congenital Cataracts

ABSTRACT

Congenital cataracts account for a significant proportion of blindness in children worldwide. They affect approximately 12–136 per 100,000 births worldwide. A genetic etiology is present in a large proportion of patients and can lead to isolated cataracts or those in the context of genetic multisystem disorders. We present two examples of genetically determined childhood cataracts and briefly review the work-up of such patients. Mutations in numerous genes have been identified that cause congenital cataracts, such as those encoding for crystallins, connexins and aquaporins, as well as some developmental regulatory proteins. Identifying the genetic or molecular etiology of congenital cataract is essential for identifying and better understanding the pathways leading to this disease, and for providing individualized genetic counseling and guiding treatment for possible associated systemic problems.

KEYWORDS:

• Congenital cataract
• genetic counseling
• molecular testing
• cerebrotendinous xanthomatosis

Disclosure statement

No potential conflict of interest was reported by the author(s).